The affiliate stated the customer reported falsely elevated beta human chorionic gonadotrophin (bhcg) result, for one patient, involving the access® total bhcg reagent used in conjunction with the access® 2 immunoassay system.The customer stated the falsely elevated result was released out of the laboratory.There was no report of patient injury or change in patient treatment associated with this event.The physician requested the sample be reanalyzed as an alternate methodology produced a negative bhcg result.The patient's sample was reanalyzed, on the same instrument, and generated lower results, within the normal reference range of the assay.The patient's sample was collected in 6 ml serum separation tube (sst) and centrifuged at 3,000 rpm (rotations per minute) for ten minutes.The sample was stored at ambient temperature.No sample integrity issues were noted.The customer stated quality control (qc) was within the laboratory's established limits prior to and after the event.No system issues were reported.The instrument was in normal operation.
|